disilver-oxide and Postoperative-Complications

disilver-oxide has been researched along with Postoperative-Complications* in 3 studies

Trials

2 trial(s) available for disilver-oxide and Postoperative-Complications

ArticleYear
[Comparison of gold-plated silver- and silver oxide-impregnated silastic tympanostomy tubes: a randomized, prospective clinical trial].
    Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7

    The insertion of tympanostomy tubes is the most common surgical procedure in the world. A major complication of chronic intubation is infectious otorrhea. The present study compares the rate of infectious otorrhea and survival rate of gold-plated silver tubes (GPR) vs. Silver Oxide-Impregnated Silastic Tubes (SPR).. The prospective, randomized clincial trial was conducted with 116 children (59 female, 57 male) aged between 16 and 127 months (median: 51 months). Bilateral insertion of ventilation tubes was performed with SPR on one side and GPR on the other side in all children. The resulting data were compared using 2-tailed Wilcoxon-test.. Out of 116 children, 11 left the study, 26 children finished the study by extrusion of both tubes, 32 children lost one tube and 47 children lost no tube. Total follow-up of GPR and SPR amounted to 703 and 949 months, respectively. Mean survival rate of SPR and GPR was 9.9 +/- 4.6 and 7.0 +/- 3.4 months, respectively (p < 0.001). During the first postoperative week, 13% of children suffered from otorrhea; after the first postoperative week until extrusion of the tubes, otorrhea was observed in 55% of children. The ratio otorrhea/months amounted to 0.046 and 0.05 in SPR and GPR, respectively (p: n. s.).. Survival rate of SPR is significantly longer than compared to GPR. No differences in the otorrhea rate of SPR vs. GPR are detectable. The longer survival rate of SPR seems to be independent of the rate of infectious otorrhea but depends probably on other effects of biocompatibility.

    Topics: Anti-Infective Agents; Cerebrospinal Fluid Otorrhea; Child; Child, Preschool; Data Interpretation, Statistical; Dimethylpolysiloxanes; Female; Follow-Up Studies; Gold; Humans; Infant; Male; Middle Ear Ventilation; Oxides; Postoperative Complications; Prospective Studies; Silicones; Silver Compounds; Time Factors

2006
Antimicrobial activity of silastic tympanostomy tubes impregnated with silver oxide. A double-blind randomized multicenter trial.
    Archives of otolaryngology--head & neck surgery, 1995, Volume: 121, Issue:5

    To test the null hypothesis that impregnation of tympanostomy tubes with silver oxide did not alter the rate of postintubation otorrhea.. Multicenter, double-blind, randomized clinical trial.. Rates of postoperative otorrhea during a 1-year study in ears implanted with Silastic tubes compared with contralateral, identical tubes impregnated with silver oxide.. Eight sites in the United States, 125 children aged 1.5 months to 12 years who had bilateral otitis media with effusion or bilateral recurrent acute otitis media.. The overall incidence of postoperative otorrhea was 9.78% in the control ears and 5.08% in the ears with silver oxide-impregnated tubes (P = .01), but no effect was seen during the immediate postoperative period. Granulation tissue was seen adjacent to the tube during two visits in the ears with standard tubes (0.54%) and during two visits in the ears with experimental tubes (0.53%); cholesteatomas did not occur in either group.. Silastic tubes impregnated with silver oxide seem to diminish the incidence of postoperative otorrhea in ears requiring long-term ventilation.

    Topics: Anti-Infective Agents; California; Cerebrospinal Fluid Otorrhea; Child; Child, Preschool; Double-Blind Method; Female; Florida; Humans; Incidence; Infant; Male; Middle Ear Ventilation; Oxides; Postoperative Complications; Silicone Elastomers; Silver Compounds

1995

Other Studies

1 other study(ies) available for disilver-oxide and Postoperative-Complications

ArticleYear
Otorrhea after insertion of silver oxide-impregnated silastic tympanostomy tubes.
    Archives of otolaryngology--head & neck surgery, 1999, Volume: 125, Issue:4

    Silver oxide-impregnated tympanostomy tubes have been shown to decrease the incidence of postoperative otorrhea, but without a significant effect in the first postoperative week.. To evaluate prospectively our results with silver oxide-impregnated tympanostomy tubes and to identify factors associated with a higher incidence of early postoperative otorrhea.. Prospective nonrandomized study.. University referral center.. Six hundred thirty patients with chronic otitis media with effusion or recurrent otitis media.. Silver oxide-impregnated Silastic tympanostomy tubes were inserted in 1254 ears. Subjects with mucoid or purulent effusions or blood at the myringotomy site at surgery were treated with topical antibiotic prophylaxis (sulfacetamide sodium-prednisolone acetate or neomycin sulfate-polymyxin B sulfate-hydrocortisone) for 5 days after tympanostomy tube placement.. Incidence of otorrhea after tympanostomy tube insertion at 1 week and 1, 3, 6, 9, and 12 months after surgery.. The overall incidence of postoperative otorrhea was 1.9%. The incidence of otorrhea in the first postoperative week was 5.6%; the incidence of otorrhea after the first postoperative week was 1.2% (P<.001). Within the first postoperative week, a significantly greater incidence of otorrhea was noted in patients younger than 3 years (7.8%), in patients with mucoid effusions at surgery (8.6%), and in patients younger than 3 years with mucoid effusions at surgery (15.2%).. Silver oxide-impregnated tympanostomy tubes are associated with a low overall incidence of postoperative otorrhea. A significantly higher incidence of otorrhea is seen during the first postoperative week, compared with the incidence after the first week. Patients with thick middle ear effusions and age younger than 3 years have a significantly greater incidence of early otorrhea after tympanostomy tube placement.

    Topics: Anti-Infective Agents; Child; Child, Preschool; Chronic Disease; Coated Materials, Biocompatible; Exudates and Transudates; Female; Humans; Male; Middle Ear Ventilation; Otitis Media; Otitis Media with Effusion; Oxides; Postoperative Complications; Prospective Studies; Recurrence; Silver Compounds

1999